The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retrospective analysis of the efficacy and safety of disitamab vedotin (RC48) in Chinese patients with HER2-positive or HER2-low metastatic breast cancer.
 
De Zeng
No Relationships to Disclose
 
Wende Wang
No Relationships to Disclose
 
Wenwu Xue
No Relationships to Disclose
 
Minna Chen
No Relationships to Disclose
 
Xiaofen Wen
No Relationships to Disclose
 
Hui Lin
No Relationships to Disclose